Cargando…
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling
BACKGROUND: Prostate cancer development involves various mechanisms, which are poorly understood but pointing to epithelial mesenchymal transition (EMT) as the key mechanism in progression to metastatic disease. ABI1, a member of WAVE complex and actin cytoskeleton regulator and adaptor protein, act...
Autores principales: | Nath, Disharee, Li, Xiang, Mondragon, Claudia, Post, Dawn, Chen, Ming, White, Julie R., Hryniewicz-Jankowska, Anita, Caza, Tiffany, Kuznetsov, Vladimir A., Hehnly, Heidi, Jamaspishvili, Tamara, Berman, David M., Zhang, Fan, Kung, Sonia H. Y., Fazli, Ladan, Gleave, Martin E., Bratslavsky, Gennady, Pandolfi, Pier Paolo, Kotula, Leszek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749699/ https://www.ncbi.nlm.nih.gov/pubmed/31530281 http://dx.doi.org/10.1186/s12964-019-0410-y |
Ejemplares similares
-
ABI1‐based expression signature predicts breast cancer metastasis and survival
por: Regua, Angelina, et al.
Publicado: (2022) -
Novel Target Opportunities in Non-Metastatic Castrate Resistant Prostate Cancer
por: Gleicher, Stephanie, et al.
Publicado: (2021) -
In Vivo Models for Prostate Cancer Research
por: Adamiecki, Robert, et al.
Publicado: (2022) -
Structure and Function of the Nuclear Receptor Superfamily and Current Targeted Therapies of Prostate Cancer
por: Porter, Baylee A., et al.
Publicado: (2019) -
Loss of Wave1 gene defines a subtype of lethal prostate cancer
por: Sowalsky, Adam G., et al.
Publicado: (2015)